Table 1.
Enzyme | KM tRNAAsp (μM) | kcat tRNAAsp (sec−1) | kcat/KM tRNAAsp (M−1 sec−1) | KM tRNAAsn (μM) | kcat tRNAAsn (sec−1) | kcat/KM tRNAAsn (M−1 sec−1) | Specificity Ratiob |
---|---|---|---|---|---|---|---|
Wild-type | 0.77 ± 0.14 | 0.022 ± 0.001 | 2.9 × 104 | 0.83 ± 0.44 | 0.014 ± 0.001 | 1.7 × 104 | 1.7 |
L81N | 0.85 ± 0.22 | 0.028 ± 0.001 | 3.3 × 104 | 1.87 ± 0.24 | 0.026 ± 0.001 | 1.4 × 104 | 2.4 |
L86M | 0.87 ± 0.05 | 0.021 ± 0.001 | 2.4 × 104 | 2.23 ± 0.34 | 0.015 ± 0.001 | 0.7 × 104 | 3.4 |
L81N/L86Mc | [0.6] | [0.021] | [3.5 × 104] | [1.3] | [0.018] | [1.4 × 104] | [2.5] |
Full kinetic analyses were conducted with wild-type ND-AspRS and its mutants. See experimental methods section and Figure 4 for details. All experiments were run at least in triplicate.
The specificity ratio is the kcat/KM for tRNAAsp divided by the kcat/KM for tRNAAsn.
The L81N/L86M mutation did not follow Michaelis-Menten kinetics. The kinetic values presented here were extracted from tRNA concentrations ≤ 4 μM (dashed line, Figure 4D). They are shown in brackets to highlight the fact that they only represent an estimation based on low concentrations of tRNA; at tRNA concentrations ≥ 16 μM, significant inhibition was observed (solid lines, Figure 4D). See text and Figure 4 for further details.